Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Di Domenico

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Biochemical Pharmacology|November 16, 2013
Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targetsEugenio Barone, Fabio Di Domenico, D Allan Butterfield
Expert Review of Proteomics|October 15, 2013
Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancerFabio Di Domenico, Federico De Marco, Marzia Perluigi
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2015
Redox Proteomics in Human Biofluids: Sample Preparation, Separation and Immunochemical Tagging for Analysis of Protein OxidationFabio Di Domenico, Marzia Perluigi, D Allan Butterfield
Physiological Reviews|October 16, 2023
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer diseaseMarzia Perluigi, Fabio Di Domenico, D Allan Butterfield
Trends in Endocrinology and Metabolism: TEM|September 5, 2025
Biliverdin reductase-A is a key modulator in insulin signaling and metabolismAntonella Tramutola, Fabio Di Domenico, Marzia Perluigi, et al.
Frontiers in Neuroscience|July 3, 2015
Aberrant insulin signaling in Alzheimer's disease: current knowledgeGaurav Bedse, Fabio Di Domenico, Gaetano Serviddio, et al.
Neurobiology of Disease|October 8, 2013
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationEugenio Barone, Fabio Di Domenico, Cesare Mancuso, et al.
Biochimica Et Biophysica Acta|October 25, 2011
Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limitsFabio Di Domenico, Raffaella Coccia, D Allan Butterfield, et al.
CNS Drugs|August 15, 2019
Targeting Mitochondria in Alzheimer Disease: Rationale and PerspectivesChiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
Expert Review of Neurotherapeutics|September 23, 2014
Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidantsFabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|November 16, 2013
Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targetsEugenio Barone, Fabio Di Domenico, D Allan Butterfield
Expert Review of Proteomics|October 15, 2013
Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancerFabio Di Domenico, Federico De Marco, Marzia Perluigi
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2015
Redox Proteomics in Human Biofluids: Sample Preparation, Separation and Immunochemical Tagging for Analysis of Protein OxidationFabio Di Domenico, Marzia Perluigi, D Allan Butterfield
Physiological Reviews|October 16, 2023
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer diseaseMarzia Perluigi, Fabio Di Domenico, D Allan Butterfield
Trends in Endocrinology and Metabolism: TEM|September 5, 2025
Biliverdin reductase-A is a key modulator in insulin signaling and metabolismAntonella Tramutola, Fabio Di Domenico, Marzia Perluigi, et al.
Frontiers in Neuroscience|July 3, 2015
Aberrant insulin signaling in Alzheimer's disease: current knowledgeGaurav Bedse, Fabio Di Domenico, Gaetano Serviddio, et al.
Neurobiology of Disease|October 8, 2013
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliationEugenio Barone, Fabio Di Domenico, Cesare Mancuso, et al.
Biochimica Et Biophysica Acta|October 25, 2011
Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limitsFabio Di Domenico, Raffaella Coccia, D Allan Butterfield, et al.
CNS Drugs|August 15, 2019
Targeting Mitochondria in Alzheimer Disease: Rationale and PerspectivesChiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
Expert Review of Neurotherapeutics|September 23, 2014
Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidantsFabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Pageof 11